However, commercial interferon gamma (IFN-γ) release assays (IGRAs: T-SPOT®.TB and QuantiFERON®; Qiagen Inc., Valencia, California, USA), cannot discern TB from latent TB infection (LTBI) [7], [8], two infection phenotypes that differ significantly in bacterial burden. The gene discussed is IFNG; the disease is tuberculosis.